- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2024 2
2022 4
2021 12
2020 2
2019 1
2014 1

Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems. 1
Centers for Disease Control and Prevention (U.S) 1
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. 4
National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. 16
United States. Department of Homeland Security. Cybersecurity and Infrastructure Security Agency‏. 1

United States 1

Guidance 6
Press Release 1

1 - 20 of 22 Results

Refine Results

All Collections

Refine Results:

All Collections

Previous

1 2

Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 25, 2021 URL : https://stacks.cdc.gov/view/cdc/111102 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 25, 2021

No Description
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 28, 2021 URL : https://stacks.cdc.gov/view/cdc/111111 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 28, 2021

:

Updated Oct. 28, 2021
Biological risk assessment : general considerations for laboratories

CITE Title : Biological risk assessment : general considerations for laboratories Corporate Authors(s) : Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems. Published Date : March 31, 2021 URL : https://stacks.cdc.gov/view/cdc/106795 Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems. (2021). Biological risk assessment : general considerations for laboratories. Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems. "Biological risk assessment : general considerations for laboratories" (2021) Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems. "Biological risk assessment : general considerations for laboratories" , 2021 Export RIS Citation Information.

:

Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems.

March 31, 2021

:

CDC’s Division of Laboratory Systems knows that incidents involving biological, chemical, physical, and radiological hazards can have a significant ...
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : 03/10/2021 URL : https://stacks.cdc.gov/view/cdc/104168 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

03/10/2021

:

Updated Mar. 10, 2021
Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)

CITE Title : Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Feb 26, 2021 URL : https://stacks.cdc.gov/view/cdc/104491 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Feb 26, 2021

:

Updated Feb. 26, 2021• The type of specimen collected when testing for current or past infection with SARS-CoV-2 is based on the test being performe...
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Aug. 15, 2020 URL : https://stacks.cdc.gov/view/cdc/92020 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Aug. 15, 2020

:

Updated Aug. 15, 2020
Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)

CITE Title : Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.;United States. Department of Homeland Security. Cybersecurity and Infrastructure Security Agency‏.; Published Date : November 3, 2020 Pages in Document : https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html Source : Coronavirus Disease 2020 (COVID-19) URL : https://stacks.cdc.gov/view/cdc/96863 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. ...

November 3, 2020 | Coronavirus Disease 2020 (COVID-19)

:

Updated Nov. 3, 2020Summary of Recent ChangesRevisions were made on November 3, 2020 to reflect the following:• Clarification on language for the co...
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Jan. 26, 2021 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/101294 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Jan. 26, 2021 | Coronavirus Disease 2019 (CoVID-19)

:

Updated Jan. 26, 2021
Guidance for general laboratory safety practices during the COVID-19 pandemic

CITE Title : Guidance for general laboratory safety practices during the COVID-19 pandemic Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Mar. 2, 2022 URL : https://stacks.cdc.gov/view/cdc/115030 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2022). Guidance for general laboratory safety practices during the COVID-19 pandemic. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for general laboratory safety practices during the COVID-19 pandemic" (2022) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for general laboratory safety practices during the COVID-19 pandemic" , 2022 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Mar. 2, 2022

:

Updated Mar. 2, 2022
Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing

CITE Title : Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : May 18, 2022 URL : https://stacks.cdc.gov/view/cdc/117464 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2022). Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing" (2022) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing" , 2022 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

May 18, 2022

:

Updated May 18, 2022
Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing

CITE Title : Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : July 15, 2022 URL : https://stacks.cdc.gov/view/cdc/119427 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2022). Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing" (2022) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing" , 2022 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

July 15, 2022

:

Updated July 15, 2022
High containment laboratories at CDC – ffty years of excellence

CITE Title : High containment laboratories at CDC – ffty years of excellence Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Published Date : August 9, 2019 URL : https://stacks.cdc.gov/view/cdc/105139 National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. (2019). High containment laboratories at CDC – ffty years of excellence. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. "High containment laboratories at CDC – ffty years of excellence" (2019) National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. "High containment laboratories at CDC – ffty years of excellence" , 2019 Export RIS Citation Information.

:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.

August 9, 2019

:

This year marks the 50th anniversary of CDC’s rich history of laboratory work investigating the world’s deadliest pathogens.In 1969, CDC opened it...
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : June 11, 2021 URL : https://stacks.cdc.gov/view/cdc/107046 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

June 11, 2021

:

Updated June 11, 2021All clinical specimens may contain potentially infectious materials. Precautions should be taken when handling specimens suspecte...
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : June 3, 2021 URL : https://stacks.cdc.gov/view/cdc/106807 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

June 3, 2021

:

Updated June 3, 2021All clinical specimens may contain potentially infectious materials. Precautions should be taken when handling specimens suspected...
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : May 12, 2021 URL : https://stacks.cdc.gov/view/cdc/106537 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

May 12, 2021

:

Updated May 12, 2021All clinical specimens may contain potentially infectious materials. Precautions should be taken when handling specimens suspected...
Guidance for institutions of higher education (IHEs)

CITE Title : Guidance for institutions of higher education (IHEs) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : July 23, 2021 URL : https://stacks.cdc.gov/view/cdc/108282 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Guidance for institutions of higher education (IHEs). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for institutions of higher education (IHEs)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for institutions of higher education (IHEs)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

July 23, 2021

:

Updated July 23, 2021This guidance is intended for any institution of higher education (IHE) that offers education or instruction beyond the high scho...
Monkeypox : laboratory procedures and biosafety guidelines

CITE Title : Monkeypox : laboratory procedures and biosafety guidelines Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Published Date : August 22, 2022 URL : https://stacks.cdc.gov/view/cdc/120491 National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. (2022). Monkeypox : laboratory procedures and biosafety guidelines. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. "Monkeypox : laboratory procedures and biosafety guidelines" (2022) National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. "Monkeypox : laboratory procedures and biosafety guidelines" , 2022 Export RIS Citation Information.

:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.

August 22, 2022

:

Updated August 22, 2022
CDC Progress on Laboratory Safety

CITE Title : CDC Progress on Laboratory Safety Corporate Authors(s) : Centers for Disease Control and Prevention (U.S) Published Date : August 15, 2014 URL : https://stacks.cdc.gov/view/cdc/147431 Centers for Disease Control and Prevention (U.S) (2014). CDC Progress on Laboratory Safety. Centers for Disease Control and Prevention (U.S) "CDC Progress on Laboratory Safety" (2014) Centers for Disease Control and Prevention (U.S) "CDC Progress on Laboratory Safety" , 2014 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S)

August 15, 2014

:

cdc:24055cdc:24056Media Advisory For Immediate Release: August 15, 2014The Centers for Disease Control and Prevention today released a series of updat...
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Dec. 13, 2021 URL : https://stacks.cdc.gov/view/cdc/112515 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Dec. 13, 2021

:

Update Dec. 13, 2021
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 12, 2021 URL : https://stacks.cdc.gov/view/cdc/111562 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 12, 2021

:

Nov. 12, 2021

1 - 20 / 22

Previous

1 2